Phathom Pharmaceuticals I... (PHAT)
NASDAQ: PHAT
· Real-Time Price · USD
10.26
-0.21 (-2.01%)
At close: Aug 15, 2025, 3:59 PM
10.24
-0.15%
After-hours: Aug 15, 2025, 06:01 PM EDT
Phathom Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 39.5M | 28.52M | 29.66M | 16.35M | 7.32M | 1.91M | 682K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 5.04M | 3.72M | 3.81M | 2.36M | 1.38M | 426K | -223K | 121K | 123K | n/a | 168K | 175K | 149K | 128K | 135K | 130K | 131K | 125K |
Gross Profit | 34.47M | 24.8M | 25.85M | 14M | 5.95M | 1.49M | 905K | -121K | -123K | n/a | -168K | -175K | -149K | -128K | -135K | -130K | -131K | -125K |
Operating Income | -59.92M | -78.86M | -59.42M | -70.8M | -77.3M | -69.95M | -69.88M | -35.66M | -31.7M | -30.08M | -46.64M | -42.53M | -45.36M | -37.91M | -33.04M | -33.14M | -35.32M | -33.58M |
Interest Income | 1.79M | 2.64M | 3.51M | 3.71M | 3.62M | 4.31M | 3.35M | 2.72M | 348K | 1.46M | 1.29M | 726K | 112K | 7K | 6K | 8K | 13K | 14K |
Pretax Income | -75.81M | -94.32M | -74.45M | -85.58M | -91.45M | -82.85M | -79.57M | -43.24M | -40.97M | -37.81M | -55.05M | -51.09M | -50.92M | -40.66M | -35.83M | -36.66M | -36.55M | -34.84M |
Net Income | -75.81M | -94.32M | -74.45M | -85.58M | -91.45M | -82.85M | -79.57M | -43.24M | -40.97M | -37.81M | -63.45M | -59.65M | -50.92M | -43.42M | -35.83M | -36.66M | -36.55M | -34.84M |
Selling & General & Admin | 85.31M | 94.47M | 76.68M | 76.1M | 75.87M | 62.01M | 57M | 23.4M | 18.94M | 18.6M | 30.7M | 23.51M | 26.55M | 20.25M | 19.49M | 16.53M | 13.72M | 13M |
Research & Development | 9.08M | 9.18M | 8.58M | 8.69M | 7.38M | 9.43M | 13.39M | 12.26M | 12.76M | 11.48M | 15.95M | 19.02M | 18.82M | 17.66M | 13.55M | 16.61M | 21.6M | 20.58M |
Other Expenses | n/a | n/a | n/a | n/a | -6K | -43K | -14K | -197K | 3K | n/a | -89K | -11K | -2K | -7K | -17K | n/a | 10K | -1K |
Operating Expenses | 94.39M | 103.66M | 85.27M | 84.79M | 83.25M | 71.44M | 70.39M | 35.66M | 31.7M | 30.08M | 46.64M | 42.53M | 45.36M | 37.91M | 33.04M | 33.14M | 35.32M | 33.58M |
Interest Expense | 17.52M | 18.07M | 18.59M | 18.48M | 17.76M | 17.17M | 13.03M | 10.11M | 9.62M | 9.22M | 9.6M | 9.28M | 5.67M | 2.76M | 2.77M | 1.49M | 1.26M | 1.27M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | -3.93M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 99.43M | 107.38M | 89.08M | 87.15M | 84.62M | 71.87M | 70.56M | 35.66M | 31.7M | 30.08M | 46.64M | 42.53M | 45.36M | 37.91M | 33.04M | 33.14M | 35.32M | 33.58M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | 170.72K | n/a | n/a | n/a | n/a | 8.4M | 8.56M | n/a | 2.76M | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 72.47M | 71.97M | 71.05M | 64.63M | 58.56M | 58.37M | 57.29M | 56.78M | 48.5M | 42.35M | 41.31M | 38.82M | 38.27M | 38.04M | 37.76M | 37.3M | 36.64M | 36.3M |
Shares Outstanding (Diluted) | 72.47M | 71.97M | 71.05M | 64.63M | 58.56M | 58.37M | 57.29M | 56.78M | 48.5M | 42.35M | 41.31M | 38.82M | 38.27M | 38.04M | 37.76M | 37.3M | 36.64M | 36.3M |
EPS (Basic) | -1.05 | -1.31 | -1.05 | -1.32 | -1.56 | -1.42 | -1.39 | -0.76 | -0.84 | -0.89 | -1.54 | -1.54 | -1.33 | -1.14 | -0.95 | -0.98 | -1 | -0.96 |
EPS (Diluted) | -1.05 | -1.31 | -1.05 | -1.32 | -1.56 | -1.42 | -1.39 | -0.76 | -0.84 | -0.89 | -1.54 | -1.54 | -1.33 | -1.14 | -0.95 | -0.98 | -1 | -0.96 |
EBITDA | -58.12M | -78.86M | -55.66M | -66.9M | -73.48M | -65.47M | -66.36M | -33.02M | -31.23M | -28.45M | -45.28M | -41.64M | -45.1M | -37.78M | -32.92M | -35.05M | -35.16M | -33.45M |
EBIT | -58.29M | -78.86M | -55.86M | -67.09M | -73.68M | -65.68M | -66.54M | -33.14M | -31.35M | -28.6M | -45.45M | -41.81M | -45.25M | -37.91M | -33.05M | -35.18M | -35.3M | -33.57M |
Depreciation & Amortization | 172K | 177K | 193K | 191K | 197K | 214K | 185K | 121K | 123K | 146K | 168K | 175K | 149K | 128K | 135K | 130K | 131K | 125K |